With a significant increase in rabies exposures this year, Rodney Rohde, PhD, talks about seeking medical attention after animal interactions as well as clinical treatment when people have been bit or scratched.
|Videos|January 5, 2017
Is the Prevalence of Powassan Virus Increasing in Humans?
Author(s)Contagion Editorial Staff
Holly Frost, MD, pediatrics physician scientist at the Marshfield Clinic Research Foundation, in Minocqua, Wisconsin, discusses whether or not the prevalence of Powassan virus is increasing in humans.
Advertisement
Holly Frost, MD, pediatrics physician scientist at the Marshfield Clinic Research Foundation, in Minocqua, Wisconsin, discusses whether or not the prevalence of Powassan virus is increasing in humans.
Interview Transcript (slightly modified for readability)
“Powassan [virus] is an emerging infection, and so, we know that the amount of Powassan that we’re been seeing in ticks has been increasing, and the seroprevalence in mammals has been increasing. [As a result], it’s likely that we’re going to see more of this as time progresses.
I think we need to do further studies looking at what the true clinical presentation of Powassan virus is. We know very little aside from patients who have neurologic disease, because that’s the population we’ve really tested before. We also need to learn more about how patients [who] have coinfection with other tick-borne diseases, such as patients [who] have both Lyme disease and Powassan at the same time present, and if they have a higher severity of illness, or if their illness lasts for a longer period of time.”
Advertisement
Related to this article
Lori Handy, MD, provides guidance in these areas including presentation before rash onset, when patients should be considered for the inpatient setting, and what treatment looks like.
Jason Pogue, PharmD, BCPS, BCIDP, contextualizes preliminary data looking at this trial and other extended-spectrum beta-lactamase (ESBL) studies, which reopens the debate around carbapenem-sparing treatment options.
Following World Rabies Day and a CDC health advisory on a 17% rise in exposure-related calls, Rodney E. Rohde, PhD, explains what the increase means, what people should do when they have an animal bite or scratch, and how clinicians should assess risk and administer post-exposure prophylaxis (PEP).
Investigators accessed longitudinal human data from ebola virus vaccination for signals of efficacy against the Bundibugyo species now surging in the Democratic Republic of Congo.
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
Advertisement
Advertisement
Trending on Contagion Live
1
Recent Guideline Updates in the Management of Urinary Tract Infections
2
Clinical Considerations for Measles: Presentation, Treatment, and Hospitalization
3
FAQ: Rising Rabies Exposure Calls PEP Decisions Back in Focus
4
Measles Update: October 2, 2026
5